Dr. Clive Hamlin received his B.S. in Chemistry and Physics from the University of London, United Kingdom, in 1961. He also went on to earn his M.S. in Chemistry. In 1967, Dr. Hamlin earned a Ph.D. in Biochemistry from the University of Waterloo, Canada. He spent the next few years as a Postdoctoral Fellow in Biochemistry at the University of Waterloo and the University of Rochester, and in Experimental Pathology at ÐÇ¿Õ´«Ã½ and University Hospitals of Cleveland. Dr. Hamlin spent some time as an Instructor at ÐÇ¿Õ´«Ã½'s Institute of Pathology, and went on to be the Director of Clinical Chemistry from 1970 until 1995. During that time he was also an Assistant Professor in Experimental Pathology (1972-1982) and the Trustee and Director of University Medical Laboratories (1984-1995). Presently, his positions include Associate Professor of Pathology at ÐÇ¿Õ´«Ã½ (1982-), Laboratory Director at University Suburban Health Center (1985-), and Laboratory Director of the National Prion Disease Pathology Surveillance Center (2001-).
Research Information
Research Interests
- Clinical pathology, with particular interest in prion disease testing.
Publications
Hamlin CR (1999). Performance characteristics of the TOSOH Alc 2.2 plus analyzer in the quantification of hemoglobin Alc. Clin Chem Lab Med 37, 5385.
Pretlow TG, Schwartz S, Giaconia JK, Wright AL, Grimm HA, Edgehouse NL, Murphy JR, Markowitz SD, Jamison JM, Summers JL, Hamlin CR, MacLennan GT, Resnick MI, Pretlow, TP and Connell CF (2000). . Canc Res 60, 4033-4036.
Hamlin CR, Medof ME (2000). Further studies on urinary decay - accelerating factor and CD59. Ann Clin Sci 30, 316-317.
Hamlin CR (2001). Modifications to improve the sensitivity of a routine estradiol assay. Ann Clin Sci 31, 307-308.
Hamlin CR (2001). A sensitive estradiol assay performed on the Bayer ACS-180 Immunoanalyzer. Proceedings of the 14th IFCC European Congress of Clinical Chemistry, Prague, Czech Republic, 251.